Student Poster

(2-001) Comparing the post-marketing safety of compounded vs. non-compounded semaglutide: an analysis based on the FAERS data

(2-002) Respiratory Schizophyllum Commune Fungal Infection in Heart Failure: A Case Report

(2-003) Broadening the pharmacogenomics conversation: public knowledge, perspectives, and missed populations

(2-004) Combination Medroxyprogesterone and Theophylline for Adjunctive Treatment of Acute on Chronic Hypercapnic Respiratory Failure in a Community-Teaching Hospital

(2-005) Evaluating the Implementation of Services Targeting Medication Adherence in Adults with Non-Dialysis Chronic Kidney Disease

(2-006) Identifying the Incidence of Bacteremia After the Use of Probiotics in Pediatric Patients at an Academic Pediatric Hospital

(2-007) Are monoclonal antibodies targeting ErbB4–ErbB2 heterodimers effective in treating BRAF wild-type melanomas?

(2-008) Identifying the Incidence of Bacteremia After the Use of Probiotics in Neonates at a Level III Neonatal Intensive Care Unit

(2-009) Assessing the Use of Trazodone for Insomnia in Individuals with Psychiatric Disorders

(2-010) Are Endogenous ERBB4 Ligands Necessary for the Proliferation of BRAF-WT Melanoma Cell Lines?

(2-011) Utilizing Artificial Intelligence for Patient Interviewing Practice

(2-012) Buprenorphine Use Evaluation at a Large Community Hospital

(2-013) Evaluation of Adverse Event Reporting of Veozah and Brisdelle to the U.S. Food and Drug Administration

(2-014) Supporting Student Success from the Start: The Role of Pre-Assessments in Identifying At-Risk Learners within the Pharmacy Curriculum

(2-015) Awareness, attitudes, and perceived barriers toward nalmefene among Alabama pharmacists: a cross-sectional survey

(2-016) Comparison of Post-Marketing Serious Outcomes with Neuraminidase Inhibitors and Baloxavir Use in Influenza

(2-017) The emerging role of small interfering RNA therapies in hemophilia A and B: a systematic review of efficacy, safety, and cost-effectiveness

(2-018) Belonging in the White Coat: Exploring Professional Identity in First-Year Pharmacy Students

(2-020) Optimizing Pharmacy Care Management: Strategies for Identifying and Discontinuing Unnecessary Medications in Patients with Extreme Polypharmacy to Improve Adherence and Safety

(2-021) Evaluation of Ciprofloxacin/Dexamethasone Tracheitis Treatment in Tracheostomy-Dependent Pediatric Patients

(2-022) Collaborative Drug-Therapy Management for Pharmacist-Led Hypertension Clinic

(2-023) Implementation of the Birmingham Agitation Management (BAM) Protocol in Acute Adolescent Psychiatry: A Retrospective Analysis

(2-024) An Evaluation of Acute Kidney Injury with Concomitant use of Vancomycin and Piperacillin-Tazobactam: A Retrospective Chart Review

(2-025) Evaluating Paliperidone Dosage Forms Using Multi-Criteria Decision Analysis: An Assessment of Clinical, Economic, and Stakeholder Priorities

(2-026) Comparison of Creatinine Clearance Versus Estimated Glomerular Filtration Rate for Dose Adjustment

(2-027) Impact of Intravenous Fluid Shortage on Development of Pre-Renal Acute Kidney Injury

(2-028) Student Perspectives of a Rubric-based Educational Approach for Evaluation of State Pharmacy Regulation

(2-029) Social Determinants of Health as Predictors of Influenza, Pneumococcal, and COVID-19 Vaccination Uptake in Adults Living with Cancer

(2-030) Discovery of ALKBH7 Inhibitor Scaffolds Through Computational Screening for Potential Drug Induced Kidney Injury Treatment

(2-031) From Gut, Glands, and Joints to the Brain: Exploring Site of Inflammation as a Contributor to Alzheimer’s Mortality

(2-032) Inhaled Tobramycin Systemic Absorption in Lung Transplant Recipients without Cystic Fibrosis

(2-033) Risk Perceptions of Smoking Marijuana in Veterans at Risk of Cannabis-Related Adverse Effects

(2-034) Evaluation of Aspartyl(asparaginyl)-beta-Hydroxylase (ASPH) Expression for Treatment of Polycystic Kidney Disease

(2-035) Design and Synthesis of Aspartyl(asparaginyl)-beta-Hydroxylase Enzyme Inhibitors

(2-036) Rational Design and Synthesis of Aspartyl(asparaginyl)-beta-Hydoxylase Inhibitors for Measurement of ASPH Binding

(2-037) Prevalence of Perceived Poor Health by Social Factors and Chronic Disease Burden Among U.S. Adults Living with Cancer

(2-038) Evaluating Sonlicromanol (KH176) and Modafinil in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes): A Comparative Approach to Mitochondrial Dysfunction and Symptom Management

(2-039) Characteristics and Predictors of Antimicrobial Associated Deaths in the United States

(2-040) Association of Parental and Other Adult Support with Indicators of Psychiatric Disorders in Adolescents with Overweight or Obesity

(2-041) Association of Inaccurate Perceived Risk of Tobacco and Alcohol Use Behaviors with Emergency Department or Hospital Utilization in People with Diabetes or Lung Disease

(2-042) Associations of Educational Engagement and Family Support as Predictors of Substance Misuse in Adolescents Prescribed Psychotropic Medications

(2-043) Chronic Diseases and Risk of Serious Falls in Older Adult BRFSS Respondents

(2-044) Association Between Military Status and Death of Despair

(2-045) Associations of Social Vulnerability and Physical Activity with Daily Functioning in Working-Age Adults

(2-046) Torsades de Pointes Associated with Levetiracetam in an End Stage Renal Disease Patient on Continuous Renal Replacement Therapy: A Case Report

(2-047) Associations of Health Literacy Indicators with Misuse of Psychoactive Medications in United States Adult Females

(2-048) Use of Alcohol or Marijuana and Prevalence of Falls in Older Adults with Impairments Affecting Activities of Daily Living

(2-049) Association of Age Group with the Perceived Effects of the COVID-19 Pandemic on Prescription Availability

(2-050) Efficient Brain Penetrating Prodrugs for the Treatment of Schizophrenia

(2-051) Applications of Artificial Intelligence in Pharmacy Education: A Literature Review

(2-054) Antipsychotic LAI Prescribing and Administration Patterns at a Federally-Qualified Health Center

(2-055) Investigating the Relationship Between Pharmacy School Assessment Methods and Post-Graduate Outcomes: North American Pharmacist Licensure Examination (NAPLEX) Pass Rates and Residency Matches

(2-056) Prevention Strategy for Etoposide-Related Infusion Reactions and the Impact on Etoposide Phosphate Spending

(2-057) Strategic Proposal for Implementing Anti-Aging NAD+ Compounding Service in White Mountain Pharmacy.

(2-058) Kitcheck with Technician Verification for Code Tray Dispensing: Reducing Pharmacist Workload

(2-059) Outcomes of toddlers who ingested medications from the One Pill Can Kill List

(2-060) Qualitative Investigation into Student Pharmacists’ Perspectives Working with Faculty Advisors During Their Research Project in the Doctor of Pharmacy Program at One College of Pharmacy

(2-061) Impact of IV vs PO Antibiotics on Emergency Department Length of Stay and Plastic Waste in Uncomplicated Cystitis Patients

(2-062) Medications in Motion: Pharmacy-Led Education to Enhance EMS Care with Medication Expertise

(2-063) Impact of Pharmacogenomic-based Clinical Decision Support on Prescribing of Mercaptopurine

(2-064) One Step Ahead: A Targeted Approach to Fall Prevention in Older Adults

(2-065) Evaluation of Hypoglycemia in End Stage Renal Disease Patients Who Receive Insulin for Treatment of Hyperkalemia

(2-066) Pharmacotherapeutic Disparities from 2008 to 2025: Examining the Impact of Race, Ethnicity, and Sex on Medication Treatment.

(2-067) Impact of Peer Education on Pharmacy Students’ Herbal Drug Knowledge‬

(2-068) Assessing Impact of Creative Social Media Videos on Overcoming Vaccine Hesitancy Issues

(2-069) Legal Liability Concerns and Antimicrobial Management Behaviors: A Cross-Sectional Study of U.S. Healthcare Professionals

(2-070) A Retrospective Analysis of Hypocalcemia Observed in Osteoporosis Patients with Reduced Kidney Function Receiving Prolia

(2-071) Cost Efficiency of Insulin Glargine Biosimilars and its Implications for Expanded Access in Low- and Middle-Income Countries

(2-072) Skills Learned and Challenges Identified by Student Pharmacists Undertaking a Required Research Project Experience in the Doctor of Pharmacy Program: Thematic Analysis of Semi-Structured Interviews.

(2-073) Association Between Creatinine Clearance and Anti-Xa Goal Achievement in Trauma Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis.

(2-074) Analyzing Utility of Select Reversal Trigger Drugs in Adverse Drug Reaction Reporting

(2-075) Linking Beliefs and Literacy: Navigating Hypertension Care in Older Adults

(2-076) Retrospective Comparative Study of Phenobarbital and Lorazepam in Geriatric Patients with Moderate to Severe Alcohol Withdrawal Syndrome

(2-077) Evaluating Pharmacists' Authorship Trends in Leading Emergency Medicine Journals

(2-078) Assessing ChatGPT’s Ability to Assist PharmD Students in Studying for Therapeutic Exams

(2-079) Neuropsychiatric Electives in United States Colleges of Pharmacy: A Narrative Review

(2-080) Utilization of Suzetrigine for Pain Management in Hospitalized Patients: A Health-System Evaluation

(2-081) Student-Led Pharmacy Technician Certification Review

(2-082) Prevalence of Renal Dysfunction and Potential Risk Factors for Disease Progression in the Population of Jinotega, Nicaragua

(2-083) Treatment of Common Pediatric Infections: Does Race Matter

(2-084) Decreasing Duration to Dispense Compounded Sterile STAT Medications From the Central Pharmacy in a 350-Bed Community Hospital

(2-085) Exploring a Potential Link Between GLP-1 Receptor Agonists and Myodesopsia

(2-086) Understanding Industry Career Pathways

(2-087) Clinical Pharmacist Interventions on Diabetes Preventative Care Measures in Spanish-Speaking Patients

(2-088) Understanding Epidemiology and Management of Candidemia to Improve Care in a Large Municipal Safety-Net Health System

(2-089) Evaluating Clinical Pharmacist Interventions on Glycemic Control in Spanish-Speaking Patients with Uncontrolled Type 2 Diabetes

(2-090) Implementing Diabetes Care Plans to Improve Diabetes Preventative Care Screenings

(2-091) Systematic Review of the Pharmacist’s Role in Global Antimicrobial Stewardship Program Guidelines

(2-092) Impact of Diabetes Care Planning on Glycemic Control in an Underserved Setting

(2-093) Evaluation of Sodium-Glucose Cotranspoter-2 Inhibitors (SGLT2i) in Patients with Liver Cirrhosis

(2-094) Impact of Near-Peer Teaching on Entrustable Professional Activities

(2-095) Comparison of Human Chorionic Gonadotropin Versus Gonadotropin-Releasing Hormone Agonist as Triggers for Ovarian Hyperstimulation Syndrome (OHSS): A Systematic Literature Review

(2-096) Evaluation of Clonidine Administration to Wean Critically Ill Patients Off of Dexmedetomidine

(2-097) Assessment of the Therapeutic Potential of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Headache-Related Conditions

(2-098) More Than Weight Loss: Can Semaglutide Help With Depression?

(2-099) Global Impact of Pharmacist-Led Antimicrobial Stewardship Programs in Intensive Care Units: Evidence from Seven International Studies

(2-100) Evaluating Concomitant Use of Baricitinib Plus Tocilizumab for Hospitalized COVID-19 Patients

(2-101) Dual Beta-Lactam Therapy for Mycobacterium abscessus Pulmonary Disease: Evidence from Preclinical and Clinical Studies

(2-102) Emergency Department Visits and Hospital Admissions Resulting from Usage of Glucagon-Like Peptide-1 Receptor Agonists

(2-103) Evaluation of Cytokine Receptor Like Factor 2 as a Predictive Biomarker Across Multiple Tumor Types using Flow Cytometry

(2-104) Assessing Hypertension Management and Establishing Targets in Individuals Requiring Hemodialysis

(2-105) Withholding of Erythropoietin-Stimulating Agents in Hospitalized Patients

(2-106) Improving Outcomes in Heart Failure: A Retrospective Analysis of Intravenous Iron Therapy for Iron Deficiency

(2-107) Empiric Meropenem for Febrile Neutropenia in Pediatric Transplant and Cellular Therapy: Time for a Targeted Approach?

(2-108) Determining the appropriate dosing of epoetin alfa for initiation and titration in patients with anemia of chronic kidney disease.

(2-109) Dispensing Match Success: Preparing for the Match with a Residency Readiness Elective

(2-110) Next Generation Hydrogel Platforms for Cancer Immunotherapy: Clinical Opportunities and Translational Challenges

(2-111) Leveraging Diverse Artificial Intelligence Tools to Enhance Assessment Activities in US Professional Pharmacy Education: Opportunities and Challenges

(2-112) Trust but Verify: Validity and Reliability Evidence for Workplace-Based Assessment Tools in Doctor of Pharmacy Programs

(2-113) Elucidating Exogenous Drugs and Metabolites Using Untargeted Metabolomics in Human Milk Samples

(2-114) Budesonide Exposure and Therapeutic Antifungal Interaction Assessment in Post-Allogeneic Hematopoietic Stem Cell Transplant Patients

(2-115) The Impact of Homeopathic Remedies on Pain Scores in Pain Management: A Systematic Review and Meta-Analysis

(2-116) Assessing the Impact of the Pharm2Home Initiative on Medication Adherence

(2-117) Evaluating the Impact of De-labeling “Low-risk” Penicillin Allergies

(2-118) Implementation of an Intensive Post-Discharge GDMT Optimization Pilot in Heart Failure

(2-119) From Grading to Guiding: How Rubrics Improve Student Performance

(2-120) Pharmacy Student Perceptions and Educational Needs on Cannabis, Vaping, and Cigarettes

(2-121) Hypnotic Use in an Adolescent Behavioral Health Facility

(2-122) Evaluating the Clinical Reasoning of Generative AI in Palliative Care: A Comparison with 5 Years’ of Pharmacy Learners

(2-123) Venous Thromboembolism Chemoprophylaxis in Hospitalized Patients Undergoing Hematopoietic Stem Cell Transplant

(2-124) Pharmacovigilance Analysis of Accelerated vs. Traditional Vaccine Approvals: COVID-19 and RSV

(2-125) The Role of Underlying Socioeconomic Traits in Trusting Community Pharmacists Among People with HIV

(2-126) Impact of Pharmacists on Glucocorticoid Exposure in Rheumatology Patients

(2-127) Optimization of OBGYN Anesthesia Trays and Kits Enterprise Wide

(2-128) Chronic Exposure of Monoclonal Antibodies in Tissue and Its Impacts on HIV Cure Neutralizing Antibody Therapeutics

(2-129) Evaluation of TPMT and NUDT15 Testing in the Clinical Management of Azathioprine Therapy

(2-130) Improving Outpatient Antibiotic Prescribing for Veterans with Urinary Tract Infections

(2-131) Clinical Pharmacology of Immunomodulators and Traditional Oncology Agents in HIV Cure

(2-132) Gut Instincts: Medication Use Evaluation of Enteral Immunoglobulin in the Treatment of Pediatric Enteric Infections

(2-133) Deprescribing PIMs to Reduce Readmission in Elderly Patients

(2-134) Rejection vs. Infection: Dose-Dependent Effects of Anti-Thymocyte Globulin on Rejection and CMV Risk in Kidney Transplants Patients

(2-135) Risk Factors for Antibiotic Prescribing Errors in Hospitalized Adults with Urinary Tract Infections at UCSF Medical Center

(2-136) Post-Abortion Contraceptive Provision and Equity Among Medication Abortion Patients

(2-138) Advancing Access to Gene Therapy: Clinical, Regulatory and Pharmacoeconomic Pathways in Adeno-Associated Virus-Based Therapies

(2-139) Safety and Effectiveness of Cenobamate in Pediatric Patients with Refractory Epilepsy

(2-140) Physiologically Based Pharmacokinetic Modeling of Ginsenoside Rd

(2-141) Changes in Student Pharmacists' Assumptions About Healthcare Professions Through Interprofessional Collaboration

(2-142) Trends in FDA Class I or II Drug Recalls Involving Excipients (2015-2025)

(2-143) Evaluation of the Use of Poractant Alfa for Respiratory Distress Syndrome in Newborns

(2-144) Evaluating the Effects of a Commercial Probiotic Oral Thin Film on Gut Health and Digestion

(2-145) Enhanced External Counterpulsation in Post-Stroke Care: A Systematic Review

(2-146) Antibiotic Prescribing Patterns and Clinical Outcomes for Treatment of Adults with Persistent Staphylococcus aureus Bacteremia at a Veterans Affair Facility

(2-147) Undergraduate Students' Perceptions of Pharmacy Across Racial Groups and the Factors Influencing Their Pharmacy School Preferences

(2-148) Impact of a Multi-Modal Pain Order Set on Opioid Consumption in Non-ICU Trauma Patients

(2-149) Comparative Evaluation of Hemodynamic Parameters with Enhanced External Counterpulsation (EECP) and Normatec 3 Compression Therapy: A Pilot Analysis

(2-150) Evidence-Based Pharmacologic Management of Prostate Cancer and the Evolving Responsibilities of the Pharmacist

(2-151) Analysis on the Contribution and Impact of Mentorship on the Development and Success of Student Pharmacists

(2-152) Budget Impact of CAR-T Therapy vs Standard Care for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Adults: A US Payer Perspective

(2-153) Guideline-Directed Medical Therapy (GDMT) Utilization and Survival Rates in the Left Ventricular Assist Device (LVAD) Population

(2-154) Use of Adjunctive Amantadine for Treatment of Pediatric Catatonia

(2-155) Impact of Pharmacist Led Insulin Management on Glycemic Control

(2-156) Real-World Effectiveness and Safety of Liposomal Cytarabine and Daunorubicin in Secondary Acute Myeloid Leukemia at Norris Comprehensive Cancer Center

(2-157) Methyl Mercury Metabolism in Man: Pharmacokinetic Analysis

(2-158) Unmasking Neurosyphilis in a Patient with Schizophrenia: Diagnostic and Treatment Challenges

(2-159) High Acceptance, High Impact: Pharmacist Interventions in Non-ICU Multidisciplinary Rounds

(2-160) Novel Topical Delivery of Dantrolene for Skin Cancer Prevention

(2-161) Evaluating the Educational Impact of AI-Virtual Simulated Patient Case Scenarios in Pharmacy Education

(2-162) Evaluating the Effect of Intravenous Acetaminophen on Pain Reduction in the Emergency Department: A Non-Opioid Approach Aligned with Colorado’s Opioid Safety Initiatives

(2-163) Heparin vs Bivalirudin in ECMO Patients: a Retrospective Comparison of Anticoagulation Outcomes

(2-164) Treatment of Multi Drug Resistant Organism Urinary Tract Infection Associated With Caudal Regression Syndrome: A Patient Case

(2-165) Bleeding risk considerations with dietary supplements targeting individuals with menopausal symptoms

(2-166) Investigation and Characterization of SOX-2 Protein from an E. coli Recombinant Source

(2-167) Assessing Compliance With Urinary Neutrophil Gelatinase–Associated Lipocalin Testing to Improve Acute Kidney Injury Monitoring in Pediatrics

(2-168) Comparing the Ability of Pharmacists and Pharmacy Students to Detect Turbidity in Simulated Intravenous (IV) Solutions

(2-169) Evaluating Meningitis/Encephalitis Panel Use in Suspected Central Nervous System Infections at an Urban Safety-Net Hospital.

(2-170) A Comparative Evaluation of Generative Artificial Intelligence and Traditional Resources in Drug Information Retrieval in Acute Care Internal Medicine

(2-171) Assessing the Implementation of a Revised Potassium Replacement Protocol for Hypokalemia in a Community Hospital Setting

(2-172) Impact of Provider Education on Oral Antibiotic Dosing for Gram-Negative Bacteremia: A Quasi-Experimental Survey

(2-173) Evaluating the Quality of AI-Generated Rubrics and Grading Reliability in Student Reflection Assessment

(2-174) Evaluating Utilization Trends of Bezlotoxumab in Patients with Clostridioides difficile Infection to Explore Market Discontinuation

(2-175) Evaluating Physical Activity and Barriers to Exercise Among Healthcare Graduate Students: A Cross-Sectional Study

(2-176) Stability of Alteplase-Dornase-alpha in Polypropylene Syringes at Room Temperature and 4⁰C

(2-177) Linezolid as Salvage Therapy for Pediatric Staphylococcal Meningitis: A Case Report

(2-178) Taxing Tobacco and Treating Dependence: Machine Learning Analysis of Smoking Cessation Prescription Claims

(2-179) Leveraging AI-Driven Frameworks: Benchmarking a Large Language Model for Accurate Drug Formulation and Route Matching

(2-180) Understanding Pharmacist Knowledge, Perceptions, and Behaviors Related to Climate-Sensitive Health Hazards- A Pre-Post-Survey Study

(2-181) Adherence in Oral Oncology: Interventions by Specialty Pharmacy Services

(2-182) Kidney Health Evaluation for Patients with Diabetes Measure Performance Snapshot

(2-183) Compatibility of Y-Site Injection of Meropenem and Posaconazole

(2-184) Implementation of the Planetary Health Report Card at University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences: A Three-Year Review

(2-185) Evaluation of Ketamine in Multimodal Pain Management in the Emergency Department

(2-186) Hospital Wide Analysis of Orthopedic Post-Procedural Venous Thromboembolism Prophylaxis Recommendations: A Retrospective Review

(2-187) Updates to Oral Anticancer Medication Monitoring Parameters in a Rural Oncology Treatment Center

(2-188) Integration of the 2025 Key Potentially Inappropriate Drugs (KIDs) List at a Children's Hospital

(2-189) Protocol Development for Pharmacist-Led Conversion to Single Pill Combination Therapy in Patients with Hypertension

(2-190) Comparative Efficacy and Clinical Outcomes of Fidaxomicin versus Vancomycin in the Treatment of Fulminant Clostridioides difficile Infection

(2-191) In Vivo Pharmacokinetic Analysis of a Novel Phytoestrogen, 3-fluoro, 6,4’-dihyroxyflavone

(2-192) Comparison of Opioid Utilization in Hospitalized Internal Medicine Patients with and without Pharmacist Rounding Support

(2-193) Altitude Isn't Nice, Pack These Drugs: A Guide to Medications Used in Altitude Illness

(2-194) Utilization of Validated Home Blood Pressure Monitors to Advance Quality Improvement Measure in Hypertension Care at an Internal Medicine Clinic

(2-195) Methenamine Hippurate versus Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection

(2-196) Primary Care Provider Perspectives on Collaborative Practice Agreements with Pharmacists

(2-197) Evaluation of Gastrointestinal Polymerase Chain Reaction (GI PCR) Test Use Across a Health System

(2-198) Evaluation of Side Effects Related to Nicotine Transdermal Patch Duration in a Veterans Affairs (VA) Healthcare System

(2-199) Role of Pharmacist Experience in Guiding Pediatric Infectious Disease Therapy in the Emergency Department Based on a National Survey

(2-200) Retrospective Medication Use Evaluation of Intravenous Iron Therapy in a Veterans Affairs Healthcare System

(2-201) Evaluation of Appropriate Broad-Spectrum Antibiotics (Vancomycin + Piperacillin-Tazobactam) Initiation in the Emergency Department

(2-202) Efficacy and harms of polypills for cardiovascular disease prevention: a systematic review and meta-analysis of randomized controlled trials

(2-203) Utilization of Absolute Lymphocyte Count (ALC) to Predict Cytomegalovirus (CMV) Reactivation Upon Completion of Prophylaxis in High-Risk Liver Transplant Recipients

(2-204) Worth a Shot: Assessing the Impact of Pharmacist Administration of Vaccines to Transplant Candidates

(2-205) An Aspirin Compounded Oral Liquid for Patients with Difficulty Swallowing

(2-206) Electronic Medical Record Integration with Automated Dispensing Cabinets for Patient-Supplied Medications

(2-207) Medication Use Evaluation of Intravenous Chlorothiazide in Hospitalized Patients with Diuretic Resistance

(2-208) Medicaid Reimbursement for Pharmacist’s Clinical Services Across the United States

(2-209) Utilization of Opioid Withdrawal Protocol in a Community Hospital Setting

(2-210) An Analysis of Services Provided by Embedded Pharmacists in Primary Care Settings

(2-211) Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review

(2-212) Analysis of Medication Management During Cardiac Arrest Secondary to Hypothermia

(2-213) Epidemiology and Characteristics of Patients with ESBL Isolates: a Multi-Site Retrospective Study

(2-214) Assessing Compliance with Rabies Post-Exposure Prophylaxis (PEP) Vaccine Administration Recommendations

(2-215) Exploring opportunities for improving antimicrobial stewardship during the treatment of Extended-Spectrum Beta-Lactamase (ESBL) Urinary Tract Infections (UTIs)

(2-216) Development of Post-Transplant Diabetes Mellitus in Kidney Transplant Patients Following Pulse-Dose Steroid Treatment for Rejection in an Outpatient Clinic

(2-217) Medication Adherence and Mental Health

(2-218) Culturing Clues: Identifying Potential Risk Factors for Extended Spectrum Beta-Lactamase Infections in Intensive Care Unit Patients via A Case–Control Comparison

(2-219) Evaluation of Voriconazole Dosing Strategies and Therapeutic Drug Monitoring in Hospitalized Patients

(2-221) Epigenetic Modulation in Alzheimer’s Disease: HDAC11 Inhibition as a Novel Therapeutic Pathway

(2-222) Bridging the Gap: Student Perspectives on Curriculum Gaps and Licensure Readiness

(2-223) Bridging the Language Gap: How Pharmacists Serve Spanish Speaking Patients

(2-224) Shining a Light: Promoting Sun Safety and Skin Health in Underserved Communities

(2-226) Barriers to Accessing Glucagon-like peptide-1 (GLP-1) Medications: A Patient-reported Outcomes Survey

(2-227) Clinical Impact of Vasopressors in Critical Care Medicine: An Evidence-Based Evaluation of Efficacy, Complications, and Monitoring Strategies

(2-228) Utilization of Training Materials to Prepare Community Members to Respond to an Opioid Overdose (PrepOD Initiative)

(2-229) An Assessment of Pharmacy Burnout in Healthcare Professionals

(2-230) Beyond Blood Sugar: Comparing Blood Pressure Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists in Type 2 Diabetes

(2-231) Pharmacist, Technician, and Intern Perspectives on Pediatric Vaccine Administration in Community Pharmacies

(2-233) Pharmacists' Clinical Impact on Biosimilar Use in the Overall Treatment Landscape of Oncology Care

(2-234) Belong and Thrive: Exploring the Impact of Social Belonging on Wellness, Burnout, and Academic Success in Pharmacy Students

(2-235) Integrating Social Determinants of Health into Pharmacy Practice: A Scoping Review of System-Level Interventions and Patient Outcomes

(2-236) Evaluation of Urinary Tract Infection Management at Urgent Care Centers Within a Large Community Healthcare System

(2-237) Umbrella Review of Psilocybin and Non-Hallucinogenic Psychedelic Analogs for Treatment-Resistant Depression as Alternatives to Traditional Antidepressants

(2-238) Race to reversal: evaluation of an improved dispensing process for anticoagulation reversal agents

(2-239) Evaluating Karius Plasma Next-Generation Sequencing for Bloodstream Infections: Implications for CLABSI Surveillance

(2-241) Development of a Stimuli-responsive Nanocarrier for Prostate cancer Treatment

(2-242) Statin Use and its influence on Survival Outcomes in patients with Renal Cell Carcinoma

(2-243) Pharmacy Student Perceptions of Flexible Learning at a Single Private Institution

(2-244) Enhancing ART Adherence: Evaluating Remote Patient Monitoring Technologies in HIV Care

(2-245) Pharmacologic Management of Suicidality in a Patient with Schizoaffective Disorder and Severe Self-Injurious Behavior

(2-246) Beyond Endocrine Therapy: Datopotamab Deruxtecan vs Chemotherapy in Metastatic HR-Positive/HER2-Negative Breast Cancer

(2-247) Review of Lenacapavir for HIV Prevention

(2-248) Therapeutic Evaluation of Seizure Management and Psychosis in Schizoaffective Disorder

(2-249) Role of Integrated Outpatient Parenteral Antimicrobial Therapy Pharmacy Services on Healthcare Utilization: A Retrospective Cohort Study

(2-250) Optimizing Helicobacter Pylori Management: Insights from Vonoprazan Versus Standard Treatment

(2-251) Incidence and Management of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity in Patients Receiving Inpatient Step-Up Dosing of Tarlatamab

(2-252) Evaluative Review of Sulopenem Etzadroxil/Probenecid for Urinary Tract Infections: Clinical Evidence, Efficacy, and Safety Outcomes

(2-253) Medical Cannabis use in Cancer Pain Management: A Review of Current Literature.

(2-254) From Collapse to Comeback: A Multi-Approach Strategy in Amlodipine Toxicity

(2-255) Radioligand Therapy and Theranostics: Precision Targeting Meets Pharmaceutical Innovation

(2-256) The impact of integrated home infusion pharmacy services on healthcare utilization in patients receiving Outpatient parenteral antimicrobial therapy: A Retrospective Cohort Study

(2-257) Are Glucagon-Like Peptide-1 and Dual Glucagon-Like Peptide-1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonists Linked to Suicidal Thoughts? A Deep Dive into the Evidence

(2-258) Integrating Cardiovascular Risk Management in Oncology: Surveillance Strategies and Emerging Practices in Cardio-Oncology

(2-259) Artificial Intelligence: A New Era of Learning for Pharmacy Students

(2-260) Management of Psychosis in a Patient with Huntington’s Disease and Comorbid Schizophrenia

(2-261) The Impact of SGLT2 Inhibitors in Hospitalized Patients with Acute Decompensated Heart Failure

(2-262) Quantifying the Impact of Alternative Weight-Based IVIG Dosing on Utilization and Cost

(2-263) Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections in Women

(2-264) Unmasking the Hidden Threat: Incidence of Euglycemic Diabetic Ketoacidosis with SGLT2 Inhibitor Therapy

(2-265) Beyond Symptom Control: Exploring the Pharmacist Role in Managing Metabolic Consequences of Antipsychotics and Mood Stabilizers

(2-266) Suzetrigine: The First FDA-Approved Non-Opioid Oral Pain Signal Inhibitor

(2-267) Combined Roflumilast-Liraglutide Potently Suppress Adrenal Aldosterone Secretion Via Atrial Natriuretic Peptide

(2-268) Cardio-Oncology: Balancing Cancer Control and Cardiac Risk in Checkpoint Therapy

(2-269) Design and implementation of a new board recertification process tool for continuing professional development activities at a tertiary hospital

(2-270) Hemorrhagic Conversion of Acute Ischemic Stroke Following Tenecteplase

(2-271) Glucagon-Like Peptide-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatohepatitis: A Literature Review

(2-272) The use of SGLT2 inhibitors in cardiovascular-kidney-metabolic syndrome

(2-273) Effect of Etomidate Versus Other Induction Agents for Endotracheal Intubation on Mortality in Critically Ill Patients

(2-274) Enhancing Glycemic Control and Engagement: The Role of Continuous Glucose Monitoring and Digital Health

(2-275) Efficacy and Safety of Lutetium-177–PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Scoping Review of Current Literature

(2-276) Comparative Effectiveness of Metolazone Versus Chlorothiazide in Loop Diuretic-Resistant Acute Decompensated Heart Failure

(2-277) Glucagon-Like Peptide-1 Receptor Agonists as Emerging Therapies in Alcohol and Opioid Use Disorders

(2-278) Protecting Our Littlest Patients: A Review of Clesrovimab for RSV Prevention in Infants

(2-279) Pharmacy 2.0: Smarter Scripts with Artificial Intelligence

(2-280) Pharmacist Optimization of Antipsychotic Therapy in Schizophrenia With Religious Delusions: A Case Report

(2-281) Case Report: Safe Use of Psychotropics in a Patient With Brugada Syndrome

(2-282) Postmenopausal Psychotropic-Induced Pseudocyesis in Schizoaffective Disorder: A Case Report

(2-283) Assessing the Feasibility and Students' Perceptions on the Use of Artificial Intelligence in a Skills-Based Course

(2-284) Development of an Excel-Based PK/PD Model to Support Personalized Intravenous Antibiotic Dosing in Severe Sepsis

(2-285) Of Microbes and Psychiatry: Where Worlds Collide and Lines Begin to Blur

(2-286) Standardized Presentation Templates and Their Effect on The Students' Performance

(2-287) Evaluating the Appropriateness of aPTT Monitoring Post Anti-Xa Conversion in a Community Hospital

(2-288) Long-acting Lipoglycopeptides for Serious Gram-positive Infections in Patients with Barriers to Discharge

(2-289) Assessing the Impact of Inpatient Multimodal Pain Management on Patient Total Morphine Milligram Equivalents Post-Electronic Health Record Conversion

(2-290) Evaluation of Human Rabies Immunoglobulin Use in Post-Exposure Prophylaxis

(2-291) High-Dose Minocycline and Risk of Clinically Significant Uremia in Hospitalized Adults

(2-292) Developing a Bleeding Outcomes Documentation Lexicon for Unstructured Clinical Notes

(2-293) Evaluating PCI Stent Properties and Cardiovascular Outcomes in Patients on Dual Antiplatelet Therapy

(2-294) Impact of Formulary Changes: A Medication Use Evaluation of Tirzepatide in Chronic Weight Management

(2-295) AI-Assisted Screening in Systematic Reviews: Applications to Pharmacist-Led Interventions

(2-296) Impact of a Pharmacist Led Inpatient Antiretroviral Therapy Stewardship Program on Medication Errors

(2-297) Identifying and Addressing Barriers to Piperacillin-Tazobactam Loading Dose Administration in a Community Teaching Hospital

(2-298) Intravenous Acetaminophen Use Evaluation

(2-299) Educating with Intelligence: A Review of Opinions on AI Applications in Healthcare Education

(2-300) Comparing Outcomes of Provider-Managed versus Computerized Glycemic Management of Subcutaneous Basal-Bolus Insulin Therapy in an Acute Care Hospital

(2-301) Development of a Comprehensive Lexicon to Improve Detection of Substance Use in Electronic Health Records

(2-302) Potential Pneumococcal Vaccine (PCV21) Induced Miller Fisher Syndrome: A Case Report

(2-303) DNA Mutation Profiling in Colorectal Cancer: A Focus on LRP1B Mutation

(2-304) Effect of Two Different Types of Surfactants (Calfactant vs. Poractant Alfa) in the Management of Respiratory Distress Syndrome in Infants

(2-305) De-Escalating Inhaled Corticosteroid (ICS) in Patients with Chronic Obstructive Pulmonary Disease (COPD)

(2-306) Insulin Administration Route and Glycemic Outcomes in Patients Receiving Parenteral Nutrition

(2-307) Evaluating Agitation in TBI Patients After Switching Anti-seizure Medications: Levetiracetam to Lacosamide

(2-308) Intravenous Phenobarbital for Moderate to Severe Alcohol Withdrawal in the Emergency Department

(2-309) Factors Associated with Inappropriate Dosing of Direct Oral Anticoagulants Across Healthcare Settings: A Systematic Review of Real-World Evidence

(2-310) Evaluation of Cefepime Dosing in Patients with Septic Shock and Acute Kidney Injury

(2-311) From MILT to CNR: A Systems-Level Evaluation of NDC Tracking and Financial Outcomes

(2-312) All in on Safety: A Quality Improvement Proposal for High-Alert Medication Dispensing

(2-313) Evaluating the Effect of Pharmacist-Led Prospective Medication Reconciliation Prior to Discharge on Heart Failure Readmissions

(2-314) The Gene-ius Approach to Pediatric Medication Management: How Pharmacogenomic Testing Can Influence Medication Regimens In The Pediatric Population

(2-315) Integrating Pharmacist-led Pharmacogenetics Clinic into Family Medicine

(2-316) Heparin Monitoring After Oral Xa Inhibitor

(2-317) Factors Associated With Dose Selection and Adjustment of Direct Oral Anticoagulants in Chronic Kidney Disease: A Subanalysis Within Systematic Review

(2-318) Evaluation of Rituximab use in a Multi-Hospital Health System

(2-319) Review of the Perspectives and Attitudes on the Clinical Implementation of DYPYD and UGT1A1-Guided Chemotherapy in Oncology Clinics

(2-320) Retrospective Evaluation of Fixed-Dose Rasburicase (3 mg vs. 6 mg) for Uric Acid Normalization in Tumor Lysis Syndrome

(2-321) Medication Use Evaluation of Antipseudomonal Therapy for Intra-Abdominal Infections at a Large Community Teaching Hospital

(2-322) Evaluating Intravenous Hydralazine Use in Hospitalized Patients at an Academic Medical Center

(2-323) Comparing Multi-Modal Simulation-Based Learning for Health Equity Communication in Pharmacy Education: A Mixed-Methods Study of Video, Text, and AI-Generated Scenarios

(2-324) Impact of Medically Integrated Specialty Pharmacy Services on Outcomes in Metastatic Prostate Cancer Patients Receiving Androgen Receptor Pathway Inhibitors

(2-325) Evaluation of Intravenous Diltiazem Use in Atrial Fibrillation with Rapid Ventricular Rate

(2-326) Retrospective Review of Vasopressor Extravasations in a Multi-Hospital Health System

(2-327) Laparoscopic Roux-en-Y Gastric Bypass for Treatment-Refractory Idiopathic Gastroparesis: A Case Report

(2-329) Design, Implementation, and Evaluation of a Telephone and EHR-Based Clinical Pharmacogenomics Service (CPGxS) at a Multi-State Pediatric Health System

(2-330) Assessing Patient Medication Education Materials Across Drug Databases: A Content and Readability Study

(2-331) Descriptive analysis of Stress Ulcer Prophylaxis prescribing practices in thermal injuries

(2-332) Impact of Partial Fidaxomicin Courses Followed by Oral Vancomycin on Clostridioides difficile Infections

(2-333) Protecting the Asplenic Patient: An Evaluation of Post-Splenectomy Vaccine Compliance

(2-334) Evaluating the Use of Diltiazem for Rate Control in Emergency Department Patients with Heart Failure and Reduced Ejection Fraction

(2-335) Safety Comparison of Alteplase vs. Tenecteplase for Thrombotic Management: A Retrospective Observational Study

(2-336) Thigh skin infection following alternate site placement of a continuous glucose monitor sensor

(2-337) Evaluation of Cardiovascular Risks of Gabapentinoids in Geriatric Populations: A TriNetX Comparative Outcomes Analysis

(2-338) A Retrospective Analysis of Tafamadis Prescribing Patterns in Transthyretin Cardiac Amyloidosis in a Large Academic Center in the Southeastern United States

(2-339) Assessing Interprofessional Competency Development Among Health Professions Students During a Global Medical Mission to Medellín, Colombia

(2-340) Comparative analyses of safe consumption sites and implications for the pharmacy profession

(2-341) Use of cefazolin and ertapenem vs monotherapy in persistent methicillin sensitive Staphylococcus aureus bacteremia

(2-342) Cognitive Impairment, Anticoagulation, and Clinical Outcomes in Older Adults with Atrial Fibrillation: Insights from the Systematic Assessment of Geriatric Elements in Atrial Fibrillation (SAGE-AF) Study

(2-343) Development of a Student-Pharmacist Led Medication Review Initiative to Support Appropriate Medication Use in Older Adults

(2-344) Retrospective Analysis of Suspected Fluoroquinolone-induced QTc Abnormalities Among Inpatients Within an Academic Healthcare System

(2-345) Assessing Antibiotic De-escalation in Uncomplicated Gram-negative Bacteremia with Oral Step-down Therapy

(2-346) Hypertonic Saline Use for Diuretic Resistance in Patients with Heart Failure

(2-347) Feasibility and Effectiveness of Pharmacist-Driven Penicillin Allergy De-Labeling Intervention in a Community Hospital

(2-348) Assessing Diagnostic Accuracy and Treatment of Inpatient UTIs: An Evaluation Based on 2010 IDSA UTI Guidelines

(2-349) A Case Report of Using Cyclosporine to Treat DRESS Syndrome Due to Lamotrigine

(2-350) Social Media Influencers & Prescription Drugs on Instagram Reels: A Content Analysis

(2-351) From IRB Approval to Implementation: Evaluating Medication Therapy Management (MTM) Services on medication adherence in Children with Special Healthcare Needs (CSHN)

(2-352) Polypharmacy in elderly patients with neurological disorders

(2-353) Title: Impact of End-of-Class Formative Math Assessments on Student Confidence and Exam Preparation in a Pharmacokinetics Course

(2-354) Orthostatic hypotension in an elderly patient following COVID-19: The interplay of comorbidities and polypharmacy

(2-356) Student Pharmacist Perspectives on Persons with Substance Use Disorder: Associations Between Education, Personal Connection, and Stigma.

(2-357) Exploring Pharmacy Students' Perceptions of Podcasts as a Supplemental Learning Tool Across Immunology and Cardiology Topics in Pharmacy Curriculum

(2-358) Evaluation and Referral Patterns for MASLD/MASH Risk in Patients with Type 2 Diabetes at a Free Clinic

(2-359) Evaluating the Impact of GLP1-RA and SGLT2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease

(2-360) In Silico Assessment of Ketamine Analogs as Lead Molecules for Novel Treatments of Neuropsychiatric Disorders

(2-361) Characterizing the Migraine Population within the St. Joseph’s/Candler Health System Emergency Departments: Demographics and Treatment Patterns

(2-362) Evaluating the impact of oxytocin-induced labor on neonatal hypoglycemia in pregnant patients with gestational diabetes

(2-363) Evaluating Patient Perceptions of Skin Disease during Pharmacist Interventions in Atopic Dermatitis

(2-364) ChatGPT in hypertension care: accuracy, usefulness, and impact variability in medication management

(2-365) Developing an AI-enhanced Training Program to Foster Clinical Counseling Skills in Pharmacy Education

(2-366) Evaluation of statin prescribing practices for patients in the statin use in persons with diabetes (SUPD) quality measure

(2-367) Assessment of N-Acetylcysteine Use at a Regional Teaching Health System in Georgia

(2-368) Predictive factors associated with progression of healthcare utilization and hospitalization in patients with sickle cell disease

(2-369) Impact of history of depression, anxiety, or post-traumatic stress disorder on maximum cumulative dose of ketamine required in intubated patients

(2-370) Cost-Effectiveness of Radium-223 Dichloride (Xofigo) in Bone-Metastatic Castration-Resistant Prostate Cancer: A Markov Model with Deterministic and Probabilistic Sensitivity Analyses

(2-371) Evaluation of Bridging Anticoagulation Practices and Discharge Barriers in Hospitalized Adult Patients Receiving Warfarin

(2-372) Immune globulin and aspirin utilization in Kawasaki disease at Wellstar Medical College of Georgia

(2-373) Impact of Ideal Versus Actual Body Weight on Analgesic Requirements in MICU Patients with Obesity

(2-374) Evaluating Dose Rounding in an Infusion Pharmacy for Chemotherapy Drugs to Optimize Pharmacy Savings

(2-375) Evaluation of large language models' reasoning methodology to identify drug-drug interactions in intensive care unit medications

(2-376) Examining Thrombotic and Ischemic Events Following the Reversal of Direct Oral Anticoagulants in Medicare Patients

(2-377) Empiric Pseudomonas Coverage in the ICU: Piperacillin-Tazobactam vs Cefepime

(2-378) Impact of Time from ICU Admission to Ketamine Initiation on Delirium Assessed by CAM-ICU

(2-380) Trends in Residency Training: PGY2 Resident Perspectives

(2-381) Incidence of Hyperkalemia with Trimethoprim-Sulfamethoxazole Prophylaxis after Liver Transplant

(2-382) Evaluating the Impact of a Pharmacist-integrated Primary Care Team on Hospitalizations and Emergency Department Visits in an Uninsured Population

(2-383) Evaluating Factors Affecting Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) Documentation in Mechanically Ventilated Patients Receiving Ketamine

(2-384) Development of a Mouse Pharmacokinetic–Xenograft Database to Enhance Translational Oncology Modeling

(2-385) MRSA PCR–Guided De-escalation in Nonpurulent Facial Cellulitis

(2-386) Doxycycline and Ceftriaxone for Synergistic Treatment of Vibrio Cellulitis

(2-387) Evaluation of Large Language Model Reasoning Methodology for Applying a Pneumonia Knowledge Graph

(2-388) AI Versus Human Consensus: Correlation of Rubric-Based Scoring in Pharmacy Counseling

(2-389) The Repurposing of Metformin: Can Metformin Be Used as an Anti-Cancer Treatment

(2-390) Impact of Pharmacist Care Team Integration in the Primary Care Setting on Preserving Renal Function in Uninsured Patients

(2-391) Medication Use Evaluation of Daptomycin Prescribing in a Non-ICU Setting

(2-392) Susceptibility Trends for Stenotrophomonas maltophilia Over a Five-Year Period at a Community Hospital

(2-393) Daptomycin Prescribing Practices in Critically Ill Patients

(2-394) Assessing ChatGPT’s Accuracy and Usefulness in Hyperlipidemia Medication Management

(2-395) Problem Solving Antimicrobial Resistance: Leveraging CDC’s National Healthcare Safety Network (NHSN)’s Survey Data on Performance Indicators to Improve Antimicrobial Stewardship Programs in Georgia Hospitals

(2-396) Post-Marketing Safety Signals: A Five-Year Comparative Analysis of FDA Adverse Event Reporting System and EMA EudraVigilance for Drugs Approved Between 2010 and 2015

(2-397) Appropriate Use of Micafungin: Assessment of Provider Compliance within a Large Academic Medical Center

(3-001) Correlation of Medication Adherence and Heart Failure Readmission Rates at the State Level For Medicare Beneficiaries in 2023

(3-002) Comparison of Medicare Prescribed Oral Semaglutide with Heart Disease Deaths and Prevalence of End-Stage Renal Disease by State in 2022

(3-003) Discovery of Antimicrobial Constituents from the Flowers of the Hawaiian Medicinal Plant Dodonaea viscosa

(3-004) Establishing a Comprehensive Database of Interactions Between Hawaiian Medicinal Herbs and Anticancer Drugs

(3-005) Comparison of Medicare Tirzepatide Prescribing and Cardiovascular Deaths by State

(3-006) Comparison of Medicare Semaglutide Prescribing and End Stage Renal Disease by State

(3-007) National Prescribing Trends of Metformin Before and After the 2022 Treatment Guideline Update

(3-008) Predictors of Early Career Development in Pharmacy: The Impact of Rotations, Curriculum, and Extracurricular Activities on Residency Match Competitiveness

(3-009) Analysis of Prescribing Patterns of Incretin-Based Therapies in Patients with Type 2 Diabetes in a Primary Care Clinic

(3-010) Evaluation of Sodium Glucose Cotransporter 2 Inhibitor Use in Patients with Type 2 Diabetes in a Primary Care Clinic

(3-011) Examining Temporal and Geographic Variation in Medicare Part D Naloxone Utilization from 2016 to 2023

(3-012) Prescribing Trends of Loop Diuretics Among Medicare Beneficiaries in the United States (US), 2021-2023

(3-013) Developing Opioid Prescribing Educational Modules Tailored for Providers in Hawaii

(3-014) Impact of COVID-19 on Cervical Cancers Screening in Guam and Hawaii

(3-015) Number of Pharmacies per Population and Cardiovascular Mortality Across Hawai’i Counties

(3-016) Comparison of Intravenous Aprepitant and Oral Aprepitant for Post-Operative Nausea and Vomiting Prophylaxis

(3-017) Retrospective before and after Evaluation of the Two-Bag Method for the Management of Diabetic Ketoacidosis within a Medical Center

(3-018) Hawaii Pacific Health System Standardization of Hypercalcemia Management: Focus on Calcitonin Injection

(3-019) Beyond Diabetes: GLP-1 Agonists as Neuroprotective Allies Against Alzheimer’s Progression

(3-020) Implementing a Continuing Professional Development Framework at St Luke’s Health System in Response to the Idaho Board of Pharmacy “Standard of Care” Model

(3-021) Clinical Impact of the Absence of Rapid Sequence Testing in Bloodstream Infections

(3-022) Pharmacist Integration in a Cystic Fibrosis Clinic: Evaluation of Patient Access

(3-023) Evaluation and Optimization of Empiric Antibiotic Selection for Trauma-Related Injuries at a Community Hospital

(3-024) Regulation of cardiac neutral lipids by synthetic glucocorticoid and GLP1 analog in male and female mice.

(3-025) The Anti-Cancer Effect of the Marine Alkaloid Manzamine A and its Analogues in Ovarian Cancer Cells

(3-026) Evaluating the use of Artificial Intelligence in Pharmacy Law Education

(3-027) Evaluating the Impact of PharmAcademy on Pharmacy School Matriculation and Career Interest

(3-028) Risk of Cardiovascular Disease and Healthcare Accessibility Among a Cohort of Underserved Chinese Americans in Chicago Chinatown

(3-029) Pharmacy vs. Optometry: Error Disclosure Simulation Outcomes

(3-030) Community Pharmacy Insights on the Over-the-Counter Contraceptive, Norgestrel: Availability, Perceptions, and Practices

(3-031) Evaluating the Influence of Pharmacy Students’ Professional Identity: A Longitudinal Study

(3-032) Incidence of Vancomycin Flushing Syndrome in Pregnant Patients

(3-033) Obesity Patterns among Adolescents in the United States

(3-034) Stigma in Mental Health: Evaluating Educational Interventions for Pharmacy Students

(3-035) Evaluating and Enhancing Clinical Decision Support for Pediatric Pharmacists: A Quality Assessment of the Kosmas 4 Kids System

(3-036) Improving Prenatal Health: Assessing Prenatal Vitamin Use After Student Pharmacist Education Among Women in Montego Bay, Jamaica

(3-037) Furoscix - Subcutaneous Furosemide for Outpatient Diuresis to Prevent Hospital Admission for Acute Decompensated Heart Failure

(3-038) Impact of QR Codes on Modern Patient Education

(3-039) Development of a Medication Card for Cystic Fibrosis Education

(3-040) The Impact of the BioFire Blood Culture Identification 2 (BCID2) Panel and Pharmacist-Driven Interventions on Antibiotic De-escalation Across a Health System

(3-041) Development and Evaluation of Novel Small-Molecule LAT1 Inhibitors for the Treatment of Cancer

(3-042) Evaluating Early Initiation of Inpatient Therapeutic-dosing Anticoagulation after Acute Ischemic Stroke

(3-043) Community Pharmacists’ Knowledge and Comfort with Oncology Care

(3-044) Early Detection of Chronic Kidney Disease in High-Risk Jamaican Communities

(3-045) Evaluation of Intervention Implementation to Increase MRSA Nasal Swab PCR Tests in Pediatric Patients

(3-046) Drug Utilization Evaluation for Group A Streptococcal Pharyngitis Treatments

(3-047) Comparing Bleeding Outcomes Between Ticagrelor and Prasugrel Following Percutaneous Coronary Intervention in Elderly Patients Receiving Dual Antiplatelet Therapy

(3-048) Comparison of Unfractionated Heparin Protocols in a Single Health Center

(3-050) Adrenocorticotropic Hormone (ACTH) Stimulation Testing in Premature Neonates

(3-051) PrEP Rx: The Pharmacist Prescription for HIV Prevention

(3-052) Evaluation of the Illinois Care of Students with Diabetes Act Implementation Within Illinois Schools

(3-053) Antibiotic Use for Secondary Bacterial Pneumonia in Inpatients Diagnosed with Influenza

(3-054) Optimizing Beta-Lactam Allergy Documentation: A Pharmacy-Driven, Patient-Centered Approach

(3-055) Antimicrobial Stewardship in Pediatric Viral Respiratory Infections: A Retrospective Analysis of Antibiotic Prescribing Following Upper Respiratory BioFire Panel Results

(3-056) Evaluation of Vancomycin Dosing Protocol in Patients Receiving Intermittent Hemodialysis

(3-057) Post-exposure Rabies Prophylaxis: A clinical assessment of immune globulin dose rounding in the Pediatric Emergency Department

(3-058) Antibiotic Use in Sepsis

(3-059) Evaluation of Bispecific T-cell Engagers in Multiple Myeloma Patients at a Community Teaching Hospital

(3-060) Evaluation of Enoxaparin Dosing Strategies and Anti-Factor Xa-guided Adjustments for VTE prophylaxis in Trauma patients

(3-061) ICU Antifungal Use and Patient Outcomes: A Multicenter, Retrospective Study

(3-062) Transdermal Clonidine for Management of High Stool Output in Pediatric Short Bowel Syndrome

(3-063) Striking the Balance: Single Versus Dual Antithrombotic Therapy Following Transcatheter Aortic Valve Implantation

(3-064) Evaluation of Antibiotic Stewardship and Patient Outcomes for Community Acquired Pneumonia at an Academic Medical Center

(3-066) State-Level Legislation Analysis of Pharmacy Specific Policies

(3-067) Opioid Use Disorder Treatment in Chronic Obstructive Pulmonary Disease: The Impact of Methadone versus Buprenorphine/Naloxone on Acute Exacerbations

(3-068) Risk Factors for Cytomegalovirus Viremia After Conversion to Belatacept in Kidney Transplant Recipients

(3-069) Impact of Body Mass Index on Virologic Suppression and Seroconversion with Long-Acting Cabotegravir-Based Therapy: A Retrospective Analysis.

(3-070) Cultural Competency Can’t Wait: Student Organizations Driving Change in Pharmacy Education

(3-071) Greenlining: Engaging Pharmacy Students in Promoting Healthy Eating through a Community Dinner in Chicago’s Bronzeville Neighborhood

(3-072) Skull Base Osteomyelitis, Zygoma Abscess and Septic Arthritis of the Temporomandibular Joint: A Case Report

(3-073) Evaluating Intern Confidence and Proficiency Following a Standardized Medication Reconciliation Training Program at an Urban Academic Medical Center

(3-074) Implementing Time-Based Workload Tracking for Investigational Drug Services Using Vestigo

(3-075) Case Report: Coordinating Dose-Modified Oxaliplatin and Fluorouracil Chemotherapy with Hemodialysis in an Elderly Patient with Metastatic Gastric Cancer

(3-076) Pharmacist’s Role in Minimizing the Risk of Antidepressant-Induced Mania Across the Lifespan

(3-077) Preventing Adverse Heparin Outcomes: Trigger-tool Event Detection, Standardized Review, and Plan-Do-Study-Act Cycles

(3-079) Evaluating Educational, Clinical, Operational, and Economic Outcomes of an Intern-Led Medication Reconciliation Program Within an Urban Academic Medical Center

(3-080) Greenlining: Cultivating Cultural Humility in Future Pharmacists through Community-Based Participatory Research

(3-081) Impact of Pneumonia Order Set Utilization on Readmission Rates and Mortality: A Retrospective Evaluation

(3-082) Maribavir Pharmacokinetics During in vitro Continuous Renal Replacement Therapy

(3-083) Left Ventricular Thrombus in Severe Systolic Dysfunction: A Rare and Critical Diagnosis in Acute Heart Failure

(3-084) Evaluating the Implementation and Effectiveness of a Pharmacist-Led Smoking Cessation Initiative in an Anticoagulation Therapy Clinic: A Retrospective Analysis

(3-085) Adopting a 36-Hour Antibiotic Protocol: Enhancing Treatment Efficacy in Neonatal Early-Onset Sepsis Through Quality Improvement

(3-086) Evaluation of Transplant Induction Protocol Change

(3-087) Evaluating Pharmacist Impact in Reproductive Health: High-Income vs. Low-Income Country Contexts

(3-088) A New Generation of Inhaled Vaccines

(3-089) Formulary Management Review (FMR) of Antiepileptic Medications

(3-090) Overcoming Barriers to Pharmacists Prescribing Naloxone – A Secondary Analysis

(3-091) Evaluation of Stocking Continuous Albuterol in Automated Dispensing Cabinets in a Pediatric Emergency Department

(3-092) Evaluation of Safety of Intravenous Phenobarbital for Alcohol Withdrawal Syndrome in Patients being Discharged from the Emergency Department

(3-093) Retrospective Analysis of Tenecteplase versus Alteplase in the Treatment of Massive Pulmonary Embolism

(3-094) Time between paralytic administration and initiation of post-intubation analgesia, sedation, or both following rapid sequence intubation in the emergency department

(3-095) A retrospective analysis on the incidence of cetuximab post-infusion reactions and the need for post-infusion observation periods

(3-096) Use of Finerenone for CKD in Type 2 Diabetes: A Cross-Sectional Study at a Large Health System

(3-097) Evaluation of Pharmacist-Driven Direct Oral Anticoagulant Monitoring: A Pre/Post Analysis

(3-098) Targeting Childhood Obesity with Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Review of Semaglutide, Liraglutide, and Tirzepatide in Pediatric Weight and Metabolic Management

(3-099) The Impact of an Internal Medicine Therapeutics Elective on Pharmacy Student Confidence in Professional Communication for Advanced Pharmacy Practice Experiences

(3-100) Evaluation of Terlipressin Use at a Community Health System

(3-101) Comparison of Isoflurane To Sevoflurane In A Pediatric Patient With Refractory Status Asthmaticus: A Case Report

(3-102) One Bolus, Many Benefits: Implementing Tenecteplase for Acute Ischemic Stroke

(3-103) Exam wrapper implementation to increase metacognition in pharmacy students in a pediatric-based pharmacotherapy course

(3-104) Morganella Morganii Bacterial Meningitis in a Neonate

(3-105) Implementation of an Updated Intravenous Iron Order Panel in the Acute Care Setting: A Pre/Post Study

(3-106) Evaluation of prescribing patterns of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction in an outpatient heart failure clinic

(3-107) Evaluation and Reduction of Pediatric Precaution Alert Volume across a Large Community Health System

(3-108) Evaluation of Antipsychotic Medications Continued After the Intensive Care Unit

(3-109) Review of Methotrexate Safe Prescribing Practices Using Data from a Clinic Serving Uninsured and Underinsured Patients

(3-110) Evaluation of Therapeutic Drug Monitoring in Adult Critical Care Units at St Bartholomew’s Hospital, London UK

(3-111) Evaluation of a Near Peer-Led Review Session on Student Confidence and Objective Structured Clinical Examination (OSCE) Performance

(3-112) Outcomes of Venetoclax-Azacitidine as a Bridge to Transplant in Relapsed/Refractory AML: A Real-World UK Cohort

(3-113) Assessing Guideline-Directed Medical Therapy (GDMT) at Discharge in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF)

(3-114) Review, Evaluation, and Application of Clinical and Financial Data for High-Dose Intravenous Iron

(3-115) Comparison of intravenous neostigmine dosing schemes for acute colonic pseudo-obstruction at an academic medical center

(3-116) Health Literacy and Readability of Patient Education Pages in a Prominent Medical Journal

(3-117) Incidence of hyperammonemia related adverse events after acetazolamide administration in hospitalized adult patients with cirrhosis

(3-118) Evaluation of Severe Hypoglycemia Risk Factors in Hospitalized Patients Treated with Insulin at a Safety-Net Health System

(3-119) Evaluation of the Use of Droperidol for Acute Agitation in the Emergency Room

(3-121) Feasibility of a Pharmacist-Lead Cardiometabolic Service in an Ambulatory Care Setting

(3-122) Scaling Pharmacist-Physician Co-Visit Models: Sustained Reimbursement Opportunities in Federally Qualified Health Centers

(3-123) Comparing student goals and expectations across two cohorts in a traditional Chinese medicine study abroad program using artificial intelligence

(3-124) Evaluation of a Pharmacist Led Discharge Medication Review Process

(3-125) Evaluation of Adherence to Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus Decolonization Protocol

(3-126) Cardiotoxicity and Other Adverse Events Associated with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Two-center Retrospective Study

(3-127) A Cross-Sectional Study Assessing Media Health Literacy of Korean Adults Using the Media Health Literacy Scale (MHLS)

(3-128) Development and External Validation of a Hybrid Clinical Decision Support System to Prevent Medication Errors in Oral Anticoagulant Therapy: Integrating Rule-based and Machine Learning-Based Approaches

(3-129) Patterns of eGFR Changes with Empagliflozin in Patients Aged ≥65 Years

(3-131) Analysis of Potential Drug-Drug Interactions in Elderly Patients Taking Statins: A Retrospective Discharge Prescription Review at a Single Center

(3-132) Influence of Social Media Platforms on Knowledge and Use of Skin Lightening Products Among Saudi Females

(3-133) Nature’s Poison Pill: A case of Digoxin-like Toxicity from the Seed of Ornamental Plant Thevetia Peruviana

(3-134) A Network Analysis of Potential Adverse Events Associated with Weight-Loss Products from Online Consumer Reviews in South Korea

(3-135) Comparative Risks of Opioid-Associated Postoperative Nausea and Vomiting After Laparoscopic Hysterectomy: A Network Meta-Analysis

(3-136) Artificial Intelligence-Assisted Analysis of Dispensing Cabinet Data for Controlled Substance Monitoring

(3-137) Assessing Stakeholder Perspectives on Developing a Health-System Pharmacy Summer Internship Program in Puerto Rico

(3-138) Improving Skeletal Muscle Relaxant Stewardship in the Post-operative Setting

(3-139) Promoting the HPV Vaccine Immunization in Systemic Lupus Erythematosus (SLE) Patients: A Pharmacist-Led Educational Intervention

(3-140) Genetic Variants and Pro-Inflammatory Biomarkers Associated with Alzheimer’s Disease in Hispanics

(3-142) Doxycycline Post-Exposure Prophylaxis Awareness, Acceptance, and Accessibility among MSM/TGW in Puerto Rico: A Rapid Qualitative Study

(3-143) Outcomes of Febrile Neutropenia Management: Mortality, Treatment Duration and Economic Impact in Oncology Hospital

(3-144) Streamlining Medication Administration: Assessing the Impact of Types of Medication Packaging on Nursing Efficiency in Patient Care

(3-145) Hemoglobin A1C vs. GMI in College Students without Diabetes

(3-146) Exploring Predictors of Depression Among Pregnant, Recently Miscarried, and Postpartum Women with Opioid Use Disorder: A Cross Sectional Survey

(3-147) Impact of the longitudinal research project on pharmacy residents’ stress and feelings of personal accomplishment

(3-148) Assessing the Incidence of Severe Neutropenia in Patients Treated with Clozapine in a Metropolitan Health System

(3-149) Evaluation of Balfaxar vs Kcentra for Warfarin Reversal at an Academic Medical Center

(3-150) Urinary Retention Prevalence in Patients Initiated on Midodrine Therapy

(3-151) Comparing Diluted Human Chorionic Gonadotropin to Menotropin in Controlled Ovarian Hyperstimulation Cycles

(3-152) Evaluation and Assessment of Anticoagulation Practices for Cerebral Venous Sinus Thrombosis at a Tertiary Care Center

(3-153) Heart Failure Guideline-Directed Medical Therapy Optimization During a Hospitalization for Acute Decompensated Heart Failure

(3-154) Safety of Live Vaccinations in Pediatric Patients on Dupilumab

(3-155) Assessment of Thrombolytic Therapy for Pulmonary Embolism in a Medical ICU of a Tertiary Care Center

(3-156) Evaluation of Protocol Adherence and Clinical Outcomes with Myxredlin at a Community Medical Center

(3-157) Utilization of Thromboelastography in Assessing Coagulation Status for Patients on Direct Oral Anticoagulants (DOACs) Requiring Emergent Reversal

(3-158) Retrospective Study Evaluating Therapeutic Drug Monitoring for Short-Course Gentamicin Therapy in Neonates

(3-159) Assessing Kansas Pharmacy Preceptors’ Experiences, Knowledge, and Attitudes toward Pharmacogenomics

(3-160) Evaluation of Side Effects from Alpha-Agonist Use in Child and Adolescent Patients in an Inpatient Psychiatric Facility

(3-161) Reevaluating Penicillin Allergy in Pregnancy: A Critical Step for Optimal Group B Streptococcus Prophylaxis

(3-162) Assessing the Potential Pharmacogenomic Guideline Usage in an Outpatient Hospital Pharmacy

(3-164) Medication Use Evaluation of Bispecific T-cell Engager Therapy Protocol Adherence and Toxicity Management in a Health System

(3-165) Evaluation of Atrial Fibrillation Treatment Based on Patient Specific Factors

(3-166) Evaluation of a Pharmacist-Led Antibiotic Substitution Protocol for Penicillin-Allergic Patients Undergoing Total-Joint Arthroplasty in a Community Hospital

(3-167) Evaluation of Bivalirudin Monitoring in Pediatric Patients Requiring Extracorporeal Membrane Oxygenation

(3-168) From Infusion to Invoice: Evaluating Inpatient Utilization and Cost of MonoFerric® in a Mid-Sized Community Hospital

(3-169) Identifying Strategies to Enhance Advanced Pharmacy Practice Experiences: Insights from Students and Preceptors

(3-170) Evaluation of Oxycodone Oral Solution in Hospitalized Patients: A Quality Improvement Initiative

(3-171) Outcomes of Single-Dose Aminoglycoside Therapy for Cystitis: A Descriptive Analysis

(3-172) Safety Analysis of Glucagon-like Peptide-1 Receptor Agonists In Upper and Lower Gastrointestinal Endoscopy

(3-173) Caught in the Nick of Time: A Case Report on Nicolau Syndrome

(3-174) Assessing neutropenia and G-CSF use with sacituzumab govitecan treatment

(3-175) Impact of Task Redistribution on Pharmacist Productivity in Clinical Review at a Health-System Outpatient Pharmacy

(3-176) Dapagliflozin for Pediatric Heart Failure

(3-177) Semaglutide-Associated Musculoskeletal Adverse Effects: A Case of Polyarthritis and Myalgias in a Patient on Semaglutide Therapy

(3-178) Evaluating the Impact of a Formal Peer Tutoring Program on PharmD Student Academic Performance: A Quality Improvement Project

(3-179) Assessment of Intravenous to Oral Antibiotic Transitions in a Pediatric Hospital

(3-180) High-Dose Thiamine for Post-Cardiothoracic Operation Vasoplegic Hypotension

(3-181) Retrospective Evaluation of Clinic Capacity and Resource Utilization in a Pharmacist-Managed Anticoagulation Clinic

(3-182) Evaluation of Bowel Regimen Optimization Prior to Methylnaltrexone Use for Opioid-Induced Constipation at a Large Academic Medical Center

(3-183) Evaluation of Inpatient Cathflo (alteplase) use for Clearance of Occluded Central Venous Catheters

(3-184) Public Perception of Pharmacists in Film and Television Media Between 2013–2023

(3-185) Rapid-Onset Thrombocytopenia Caused by Piperacillin/Tazobactam: A Case Report

(3-186) PEN-FAST Scoring Utilization for Antibiotic Prescribing in Obstetric Patients

(3-187) Fighting the Epidemic: Preparing Students to Practice in the Climate of the Opioid Epidemic

(3-188) Phenobarbital in Alcohol Withdrawal Syndrome Among Trauma Patients: A Retrospective Analysis of Symptom Triggered Dosing and Scheduled Tapered Dosing.

(3-189) Comparison of Black and White Women with Breast Cancer in the Deep South and their Health Care Experiences and Access to Environments that Promote Wellbeing

(3-190) Healthy Lifestyle Tools for Diabetes Risk Reduction Among Hospitality Workers: Results from a Pharmacy-Led Pilot

(3-191) Ramelteon versus Doxepin for Insomnia in Older Adults: A Comparative Literature Review and Evidence Synthesis

(3-192) Exploring Clinical and Demographic Factors Affecting 12-month Hospitalization Status in Patients with Second-Degree AV Block

(3-193) Intravenous Levothyroxine to Oral Dose Conversion Updates within Ochsner Medical Center

(3-194) Blocked Beats: A Case of Flecainide Toxicity

(3-195) Prediabetes Risk Screening in the Hospitality Industry: A Pharmacist Led Pilot Study

(3-196) Examining Lung Cancer Knowledge & Assessing Risk Factors in Minority Communities

(3-197) Investigation of the Anticoagulant Activity of 4-[5-(4-Carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide

(3-198) Impact of Social Determinants on Chimeric Antigen Receptor T-Cell Therapy Access and Outcomes in Pediatric B-Cell Acute Lymphoblastic Leukemia

(3-199) Evaluation of Intraoperative Use of Neuromuscular Blocking and Reversal Agents in Pediatric Surgical Patients

(3-200) Pharmacist-Delivered Linkages to Care: Interventions for Diabetes Prevention Among New Orleans Hospitality Industry Workers

(3-201) Medication Use Evaluation of Methylnaltrexone at an Academic Hospital

(3-202) Evaluating Appropriateness of Levalbuterol Use in Infants Admitted to Intensive Care Units: A Retrospective Medication Utilization Evaluation

(3-203) Examining Breast Cancer Screening Practices and Healthcare Challenges Among Hispanic Women

(3-204) Impact of DoxyPEP on STI Rates and ART Adherence in Young Adults in an Outpatient Pharmacy Setting

(3-205) The Impact of Coronavirus 2019 on Screening Measures in Women: A Review

(3-206) Postmarket Safety Comparison of Sotagliflozin vs. SGLT2 Inhibitors: FDA-Labeled Important & Most Frequent Adverse Reactions vs FAERS Reports

(3-207) Evaluating Immune-Mediated Adverse Reaction Reporting for Durvalumab and Atezolizumab: A Comparison of Prescribing Information and FDA Adverse Event Reporting System (FAERS) Database

(3-208) Adjustment of warfarin dosing due to drug interactions with antimicrobial agents in a pharmacist managed anticoagulation clinic

(3-209) Bridging the Gap: Discharge Hydralazine Prescribing for Hypertension in patients with CKD and/or ASCVD

(3-210) Gabapentanoid Utilization Review in Correctional Facilities

(3-211) Evaluating the Impact of Early TPS Termination Announcement on viral suppression for Haitian patients living with HIV in Rural Maryland

(3-212) Pharmacy Engagement in Decentralized Clinical Trials: Literature Review, Trial Registry Analysis, and Feasibility Considerations for Latin America

(3-213) Temporal trends and the Influence of the COVID-19 Pandemic on Prescription Medication Use in Pediatric Patients

(3-214) Stated and Revealed Preferences for Depression or Bipolar Disorder in Adults

(3-215) Impact of Valproic Acid on Serum Nortriptyline Levels

(3-216) Safe and Appropriate Use of Over the Counter Pain Medications Among Older Adults

(3-217) Safety and Tolerability of Outpatient Linezolid Use in Durations Longer than 14 Days

(3-218) Assessing Diabetes Care: Impact of Manufacturer Support Programs in a Diabetes Clinic

(3-219) Evaluation of Performance of Daily Nebulization of Ensifentrine via Mesh Nebulizer

(3-220) Standardized Manufacturer-Controlled Doses to Reduce Controlled Substance Waste and Variances at an Academic Medical Center

(3-221) Closing the Gap in Lipid-Lowering Therapy: A Pharmacist-Driven Approach for Patients with Atherosclerotic Cardiovascular Disease (ASCVD)

(3-222) Exploring pharmacy student preparedness and preceptor expectations for soft skills in Introductory Pharmacy Practice Experiences

(3-223) Trends in Utilization of Key Potentially Inappropriate Medications in Insured Pediatric Patients

(3-224) Impact of Health Coaching on Lipid Management at a Veterans Affairs Medical Center

(3-225) Assessing Viral Suppression in Patients Receiving Crushed Dolutegravir and Enteral Nutrition

(3-226) Prenatal Exposure to Opioid Use Disorder (OUD) Treatment and Impact on Long-Term Child Development

(3-227) Beyond diabetes and obesity: the role of GLP 1 agonists in alcohol use disorder

(3-228) Exploring Stress and Fertility: Knowledge, Awareness, and Risk Perceptions Among College Students

(3-229) Discontinuing Injectable GLP-1 Receptor Agonists Upon Treatment Goal Achievement: Strategies and Outcomes

(3-230) Nutrition and the Menstrual Cycle: Insights into Perceptions and Dietary Behaviors

(3-231) Assessing the Mental Health Knowledge of the African Community Education Center's (ACE) Staff Using the Mental Health Literacy Scale (MHLS)

(3-232) Optimizing Pain Relief in Bone Metastases: A Case Report

(3-233) Literature Evaluation of the Use of GLP-1 Receptor Agonists in Heart Failure with Preserved Ejection Fraction

(3-234) Weight-Based Dosing of Enoxaparin in High-Risk Postpartum Patients After Cesarean Delivery: Evidence from Randomized Trials

(3-235) Enhancing APPE Readiness: The Role of Curricular EHRGo Training in Developing PharmD Students’ Confidence

(3-236) Comparative Review of Oral GLP-1 Receptor Agonists in Development: Efficacy, Safety, and Future Promise in Obesity Treatment

(3-237) Association Between Glucagon-Like Peptide-1 Receptor Agonist Use and Depressive Symptoms Among U.S. Adults With Type 2 Diabetes

(3-238) Semaglutide-Induced Allodynia: Two Case Reports in Chronic Weight Management

(3-239) Across State Lines: Variability and Convergence in Pharmacy Practice Standards

(3-240) Patient Perspectives on Pharmacy Support Services for Medication Management ​

(3-241) Assessing the Understandability, Actionability and Readability of Mixed Amphetamine Salts Patient education material (PEM)

(3-242) Pharmacist-Directed Transition to Automated Insulin Delivery in Two Adults with Type 2 Diabetes: Impact on Glycemic Outcomes and Insulin Use

(3-243) Challenges and Barriers to African American Inclusion in Alzheimer’s Disease Trials

(3-244) Differential Gene Expression Profiling Links Alcohol Use in Stage 2 Pancreatic Cancer to Altered Metabolic Pathways and Proteasomal Degradation

(3-245) Evaluating the use of Phytonadione in End-Stage Liver Disease in a Large Academic Medical Center

(3-246) Daptomycin-Associated Eosinophilic Pneumonia: An Evidence Review of Published Cases

(3-247) A first case report of epiploic appendagitis potentially associated with rapid weight loss secondary to tirzepatide

(3-248) Impact of Tirzepatide on Alcohol Consumption: A Case Report Highlighting the Potential Utility of Reduced Alcohol Intake

(3-249) Complete insulin discontinuation and glycemic stabilization with low-dose tirzepatide: a pharmacist-led case suggestive of pharmacogenomic variability

(3-250) Semaglutide and Tirzepatide: Impact on Lean Muscle Mass and Body Composition Changes to Inform Patient Care

(3-251) Regulatory Oversight of Artificial Intelligence in Medical Devices

(3-252) Use of 7+3 Chemotherapy After Azacitidine/Venetoclax Induction in AML: A Small Retrospective Cohort from Real-World Practice

(3-253) Detection of Endogenous Hypercortisolism During Management of Type 2 Diabetes in an Ambulatory Care Clinic

(3-254) Heart Failure: When the Flow Runs Low

(3-255) Drug-Induced Myopathy: Assessing the Interaction Between Daptomycin and Statins

(3-256) Chronotherapy in hypertension: An updated Bayesian meta-analysis of prospective randomized controlled trials comparing awakening and bedtime dosing effects on cardiovascular outcomes

(3-257) Use of Aprepitant (Emend) in controlling chemotherapy-induced Nausea and vomiting (CINV) in Triple negative Breast cancer (TNBC)

(3-258) Regulatory and Legal Challenges in the FDA’s Accelerated Approval Pathway: Balancing Evidence for Efficacy, Safety and Speedy Access to New Alzheimer’s Treatments

(3-259) Statin intolerance in HMG-CoA reductase antibody–positive myopathy: a clinical case report

(3-260) An Evaluation of Innovative Therapeutic Strategies for Low-Grade Serous Ovarian Cancer: Current and Emerging Approaches

(3-261) Assessment of Student Perceptions on Confidence of Perceived APPE Readiness to Perform Pharmacist Driven Contraceptive Prescribing and Counseling

(3-262) Pharmacy-Led Warfarin Monitoring Across a Hospital System

(3-263) AI-Powered Platform for Translating Marketing Content Updates into Sales Alignment

(3-264) Integrating Acute Care Planning into Chronic Pain Management: A Case-Based Approach

(3-265) Navigating Pain: A Pharmacist’s Role in Perioperative Medication Management for Orthopedic Surgery

(3-266) Novel Insights into Ewing Sarcoma: Pathogenesis, Conventional Treatment Options and Nanotherapeutics

(3-267) Targeting Chagas Disease with AI: Molecule Design Using AIDDISON™

(3-268) Tebentafusp Improves Survival Rates in Uveal Melanoma: Clinical Efficacy and Safety Compared to Conventional Monotherapies

(3-269) From Literature to Learning: Developing Evidence-Based Sexual and Reproductive Health Competencies for Student Pharmacists

(3-270) Medication Use Evaluation of Axatilimab in Chronic Graft-Versus-Host Disease: Appropriateness, Safety, and Pharmacoeconomic Outcomes

(3-271) Evaluation of pharmacist competency to an automatic renal dose adjustment policy

(3-272) Evaluation of Inhaler Order Accuracy and of a Pharmacist-Driven Therapeutic Interchange at a Large Academic Medical Center

(3-273) The Role of Artificial Intelligence in Tailoring Drug Therapies to Individual Genetic Profiles and Do the Benefits Outweigh the Risks

(3-274) Assessing the Prescribing Practices of Glucagon-Like Peptide-1 Receptor Agonists Among Ambulatory Care Pharmacists in Patients with Elevated Fibrosis-4 Scores

(3-275) Impact of Supportive Relationships on Psychiatric Outcomes in Breast Cancer Survivors: Implications for Pharmacist-Led Survivorship Care

(3-276) Optimizing the Medication Ordering Process Through Real-Time Prescription Benefits (RTPB) Utilization

(3-277) Unpacking Curriculum Hoarding: A Data-Driven Look at Student Learning in Pharmacy Therapeutics

(3-278) Evaluation and Optimization of International Normalized Ratio (INR) Goals in Patients with Mechanical Aortic Valves in a Pharmacist-Run Clinic: an Anticoagulation Stewardship Initiative

(3-279) Safety Outcomes of High-Dose Intravenous Lacosamide: Comparison of IV Push Versus IV Piggyback Administration

(3-280) Drug Shortage Management: A Collaborative, Team-Based Approach

(3-281) Pre-screening Black or African American Women with Breast Cancer to Increase Enrollment to Oncology Clinical Trials

(3-282) Barriers Across the Clinical Trial Enrollment Pathway: A Survey of Study Staff at 2 Large-Scale Research Sites

(3-283) Evaluating the Incidence of Infusion Site Reactions Associated with Peripheral Infusion of Amiodarone

(3-284) Pharmacy Preceptor Perceptions of Professionalism

(3-285) Potential In Vitro Epigenetic Anti-Cancer Effects of Native Hawai’ian Ginger in High-risk Neuroblastoma

(3-287) From Service to Success: Exploring the Role of Community Service in Shaping Pharmacy Student Professionalism and Career Development

(3-289) Assessment of Pharmacy Student Perceptions of Professionalism

(3-290) Phospho-Proteomic Python Analysis Using Python Reveals Aberrant Calcium Signaling in Chemoresistant High-Risk Neuroblastoma

(3-291) Prophylactic Antibiotic Use and Decolonization Practices Among Cardiovascular Surgery Patients Prior to Enhanced Recovery After Surgery (ERAS) Protocol Implementation

(3-292) Utilization of Clinical Decision Support to Ensure Safe Prescribing of Epidural/Intrathecal Medications and Anticoagulation Therapies

(3-293) Impact of glucagon-like peptide-1 (GLP-1) agonists on hypertension quality metrics

(3-294) Evaluating the Treatment of Hepatic Encephalopathy: A Single-Center Retrospective Chart Review

(3-295) Clinical Impact of Sodium-Glucose-Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Heart Failure with Preserved Ejection Fraction in Advanced Primary Care

(3-296) High-dose cephalexin vs standard-dose cephalexin for the management of cellulitis in obese patients: a single-center retrospective chart review

(3-297) Identifying the Anticoagulation Gap in Patients with Atrial Fibrillation

(3-298) Comparative Effectiveness and Safety of Daptomycin vs Vancomycin for Treatment of MRSA Bloodstream Infection in Hospitalized Adults: A Single-Center Retrospective Cohort Study

(3-299) Promissory Evaluation of VTE Prophylaxis Regimens for Hospitalized Patients with COVID-19

(3-300) Comparative Outcomes of 7-Day Versus Extended Antibiotic Therapy for Uncomplicated Male Urinary Tract Infections: A single-center retrospective chart review

(3-301) Evaluating the Impact of Rheumatoid Arthritis Pharmacotherapy Beyond Prescriptions

(3-302) Evaluation of Outpatient Therapeutic Prescribing Trends in Clostridioides difficile Treatment Using the Collaboration to Harmonize Antimicrobial Registry Measures (CHARM)

(3-303) Comparative Efficacy of 3% Saline Versus Other Hypertonic Saline Solutions for Intracranial Pressure Reduction: A Retrospective Chart Review

(3-304) Structured Interviews to Explore Individuals’ Willingness to Discuss Sexual Health Topics with Pharmacists

(3-305) Dual Antiplatelet Therapy as Secondary Prevention Following Non-Cardioembolic Ischemic Stroke: A single-center retrospective chart review

(3-306) Cefepime and Neurotoxicity: Differences in Risk by Dose

(3-307) An Inpatient Retrospective Evaluation of apixaban and rivaroxaban Loading Dose Strategies in the Setting of Acute Venous Thromboembolism

(3-308) Trends in Nirmatrelvir-Ritonavir and Molnupiravir Prescriptions in the Grand Traverse Area During the 2023-2024 Respiratory Season Compared to COVID-19 Surge During the Summer of 2024

(3-309) The Role of As-Needed Loop Diuretics in Optimizing Heart Failure Management

(3-310) Diagnostic Disconnections: International Classification of Diseases, Tenth Revision (ICD-10) Labeling and Antibiotic Use in Sinusitis Care

(3-311) Alcohol Consumption and Health in Older Adults: A Cross-Sectional Analysis Using the Health and Retirement Study

(3-312) Exploring the Optimal Lymphodepleting Chemotherapy Regimen for CAR T-Cell Therapy

(3-313) Impact of Genetic Variants on Tacrolimus Trough Concentrations in Kidney Transplant Patients during the Early Stage of Post-Transplant

(3-314) Impact of Pharmacist Services in an Ambulatory Psychiatry Clinic

(3-315) Investigating the therapeutic potential of translation initiation factor eIF4E cap-analogue inhibitors through biological characterization

(3-317) Exploring Pharmacy Pathway Programs Across the United States

(3-318) Tacrolimus dosing in patients with various CYP3A4 and CYP3A5 phenotypes

(3-319) Revisiting Recitation Sessions in Medicinal Chemistry: Evaluating the Impact of Interactive, Faculty-Led Models on Student Engagement and Academic Performance

(3-320) Impact of Education on Medication-Related Instrumental Activities of Daily Living

(3-321) Treatment Patterns for PCR-Positive Clostridioides difficile Test Results at Michigan Medicine

(3-322) Evaluation of Pharmacist Comprehensive Medication Review Prior to Annual Wellness Visits in Geriatric Patients

(3-323) Impact of Implementing Targeted Activity on Conflict Resolution Within Team-Based Learning

(3-324) FDA Complete Response Letters (2020-2024): Insights into Deficiencies in Biologic and New Drug Applications

(3-325) Safety and Efficacy of Direct Oral Anticoagulants Compared to Warfarin in Patients with Body Mass Index ≥ 40 kg/m2 In a Real-World Setting

(3-326) Oral Aprepitant for Refractory Chemotherapy-Induced Nausea and Vomiting

(3-327) Statin Therapy and Muscle Health: Insights into Muscle Damage and Myopathy Risk

(3-328) Association of CYP Genetics with Tyrosine Kinase Inhibitor Toxicity

(3-329) Faculty and Student Perceptions of the Attendance Policy in the University of Michigan College of Pharmacy PharmD Program

(3-330) Comparison of Penicillin G and Non-Penicillin G Therapy for the Management of Enterococcus faecalis Infective Endocarditis (EIE)

(3-331) Association of Nutritional Status with Severity of Paclitaxel-induced Peripheral Neuropathy

(3-332) Novel Small Molecule Compounds Targeting Glutathione S-Transferase Omega 1 (GSTO1) as Potential Therapies for Glioblastoma (GBM)

(3-333) PharmD Meets AI: Which Tool Can You Trust for Accurate and Reliable Drug Information?

(3-334) Assessing the Frequency of Antimicrobial Prescriptions for Influenza in the State of Michigan

(3-336) Clots, Bleeds, and Balancing Acts: The Perioperative Anticoagulation Puzzle in Liver Transplant Recipients

(3-337) Evaluation of the Impact of Switching from Glucagon–like Peptide-1 Receptor Agonist to Tirzepatide on the Lipid Profile in Patients with Type 2 Diabetes

(3-338) Waiting for the Answer: Consequences of Delayed VITEK-2 Susceptibilities on Antimicrobial Stewardship

(3-339) Comparative Evaluation of Artificial Intelligence Models in Responding to Drug Information Questions

(3-340) Evaluation of Pantoprazole Dosing for Acute Gastrointestinal Bleeding in an Urban Academic Center

(3-341) Projecting Generic Drug Cost Increases from Section 301 Tariffs in Workers’ Compensation

(3-342) From Classroom to Clinic: Advancing AI Integration in Academics

(3-343) Height Discrimination: Insights on Living as an Adult with Short Stature

(3-344) Evaluation of a Stewardship Nudge with a Beta-Lactam Prolonged Infusion Order Panel

(3-345) Clinical Outcomes of Medical Cannabis in Anxiety Disorders: Evidence from GAD-7 Assessments

(3-346) Long term glucagon-like peptide receptor agonists use in pediatrics

(3-347) Assessing Pharmacist Hesitancy in Regards to Providing Pediatric Vaccinations in an Outpatient Setting

(3-348) A Case Report Exploring Targeted Topical Antimicrobial Therapy in the Management of a Second-Degree Chemical Burn Infected with Multiple Bacterial Pathogens

(3-349) Real Life Outcomes with Glucagon-Like Peptide 1 Weight Management in Pediatric Patients

(3-350) Nonprofit Organization and School of Pharmacy Collaboration to Transform Diabetes Care in Underserved Rural Populations: Interim Pilot Study Results of Telehealth Medication Therapy Management (MTM)

(3-351) Real-World Insights on Cannabis for Insomnia Management

(3-352) Evaluating Medical Cannabis for Insomnia: A Systematic Review of Randomized Controlled Trials to Inform Clinical and Policy Decisions

(3-353) Infantile Botulism: Considering Maternal Botox as a Potential Factor

(3-354) Use of Tirzepatide for Lipid Modulation in Type 2 Diabetes Mellitus

(3-355) Assessment of the Use of B52 (a Combination of Haloperidol, Lorazepam, and Diphenhydramine) and Olanzapine for Acute Agitation in a Pediatric Emergency Department

(3-356) Using Oral Theophylline, a ‘Biopharmaceutics-Classification-System-I Drug, as a Probe to Investigate Circadian Variation in Steady-state Maximal Concentrations Under Two Postures-- Sitting versus Left-lateral-Decubitus.

(3-357) Impact of a Physician-Pharmacist Collaborative Continuous Glucose Monitoring (CGM) Service on Real-world Patient Outcomes in Type 2 Diabetes Mellitus: a Retrospective Analysis

(3-358) Assessment of Prophylactic Administration of Antiemetics in Pediatric Surgical Patients

(3-359) Predictors of Cefepime-Associated Delirium in Hospitalized Patients: A Multicenter, Retrospective Cohort Study

(3-360) A Drug Utilization Evaluation of Ketorolac Prescribing Patterns in a Health System

(3-361) Patient Outcomes and Factors Associated with Failure of Initial Antibiotic Therapy in Nosocomial Pneumonia

(3-362) Incidence of Hypersensitivity Reaction Among Patients Receiving Paclitaxel for Gynecologic Malignancies

(3-363) Evaluation of Intravenous and Subcutaneous Insulin with Overlapping Insulin Glargine in the Management of Diabetic Ketoacidosis at a Large Academic Medical Center

(3-364) Evaluation of the Student Test of Academic Readiness (STAR) in Predicting Future Academic Performance of Student Pharmacists

(3-365) Title: Impact of Rapid Polymerase Chain Reaction (PCR) Diagnostics on Antibiotic De-escalation in Pneumonia: A Multi-Center Real-World Evaluation

(3-366) Evaluation of Initial Opioid and Ketamine Dosing in the Emergency Department for Acute Pain

(3-367) Impact of Methylprednisolone Dose Selection for Asthma on Pediatric Intensive Care Unit Length of Stay

(3-368) Restricted for a Reason: Evaluating the Appropriateness of Remdesivir Utilization

(3-369) Assessing Adherence to a Proton Pump Inhibitor Infusion Restriction Criterion at a Large Regional Health System

(3-370) Analysis of Intravenous Levetiracetam Preparation and Administration at a Multicenter Health System

(3-371) Expanding Access to Chronic Disease Management: Pharmacist Integration in Rural Family Medicine

(3-372) Creation of a Pharmacotherapy Laboratory Experience for Long-Acting Injectable Medication Given by Gluteal Administration

(3-373) Cefazolin Minimum Inhibitory Concentration Creep in Urinary Escherichia coli and Klebsiella spps.: A Decade Review

(3-374) Review of Resistance Patterns to Anti-Pseudomonal Antibiotics Piperacillin/Tazobactam, Cefepime, Ciprofloxacin Over Time.

(3-375) Retrospective Evaluation of Twice-Weekly Versus Thrice-Weekly Sulfamethoxazole-Trimethoprim for Pneumocystis jiroveci pneumoni Prophylaxis in Immunocompromised Patients

(3-376) Assessing Concurrent Benzodiazepine and Opioid Utilization in Primary Care Settings

(3-377) Efficacy of Fixed Vasopressin Dosing in Obese vs Nonobese Patients: A Retrospective Study

(3-378) Long-Term Clinical Outcomes in Tardive Dyskinesia with Valbenazine: Evidence for Efficacy and Safety

(3-379) Effect of Pericapsular Nerve Group Block Placement in Hip Surgery Patients on Overall Opioid Utilization Through Postoperative Day Three

(3-380) Cannabis Conversations: Dispensary Perspectives on Pregnancy Related Nausea

(3-381) Evaluation of Cangrelor Transition Patterns to Oral P2Y12 Receptor Inhibitors

(3-382) Evaluation of the Long-Term Safety and Efficacy of Deutetrabenazine for Tardive Dyskinesia

(3-383) Health System Assessment of Iron Sucrose Use and Prescribing Pattern

(3-384) Dupilumab vs. Tralokinumab in adolescent patients at Children's Mercy clinics: a comparison of benefit and adverse effects

(3-385) Direct Oral Anticoagulant (DOAC) Management in a Rural Ambulatory Care Clinic

(3-386) Evaluation of Piperacillin/Tazobactam, Cefepime, and Meropenem Utilization in a Community Hospital

(5-001) Retrospective Evaluation of Reactions to Prophylactic Heparin Products in Patients with Documented Alpha-Gal Syndrome

(5-002) Treatment of Kratom Withdrawal with Buprenorphine/Naloxone During Admission for Hypertensive Emergency

(5-003) Utilization of Nasal MRSA Screening in Community-Acquired Pneumonia (CAP)

(5-004) Opioid Prescribing at Discharge Following Appendectomy or Cholecystectomy

(5-005) Assessing Pharmacist Comfort of Increasing Technician Roles in Diabetes Monitoring Programs

(5-006) Interprofessional Collaboration Between Pharmacy and Paramedicine Students to Deliver Opioid Education and Naloxone Training Across a University Campus

(5-007) Exploring the Current State of Interprofessional Education from Institutional Leaders: A Qualitative Study

(5-008) Examining Asthma Outcome Disparities in Omaha, Nebraska: A Retrospective Review

(5-009) Use of Droperidol in Undifferentiated Acute Agitation: A Protocol Review

(5-010) Associations between Required Advanced Pharmacy Practice Experience Rotation Types and Pharmacy Student Matching to an Accredited Post-Graduate Year 1 Residency

(5-011) Comparing Octopamine and Norepinephrine Activity Using Caenorhabditis Elegans as an Experimental Model

(5-012) Timing of Sedation Initiation Post-Intubation in the Emergency Department

(5-013) Investigating the Association between GRK2 and Mutations of Protein Markers for Melanoma

(5-014) Exploring the Effects of Doxorubicin and Etoposide in Primary Human Cardiomyocytes: Changes In Expression of Stat3

(5-015) Investigating the Protein Expression Relationship between GRK2 and Biomarkers for Thyroid Cancer

(5-016) Exploring the Effects of Co-Administration of Fluoxetine or Paroxetine with Doxorubicin on MDA MD 231 Breast Cancer Cell Activity- Death and Cell Number Over Time

(5-017) Evaluating LLM-Generated Summaries and Flashcards in PharmD Education: Student Perceptions and BERTScore Reliability Testing

(5-018) Exploring the Role of G Protein Coupled Receptor Kinases in Dopaminergic Behavioral Regulation in Caenorhabditis Elegans

(5-019) Targeting the JAK/STAT Axis with Baricitinib in Cervical Cancer HeLa Cells Lacking G Protein Coupled Receptor Kinase 2 or 3

(5-020) AI-Assisted Learning in Pharmacy: A Pilot Study on ChatGPT Study Guides and Student Performance

(5-021) Querying the Relationship between GRK2 and the KRAS Network in Pancreatic Cancer

(5-022) Exploring the Role of G Protein-Coupled Receptor Kinases in Serotonergic Drug-Mediated Behavior Using Caenorhabditis Elegans as an Experimental Model

(5-023) Using C. elegans as an experimental model to test the significance of G-protein coupled receptor kinase-2 during growth and development in response to excess glucose

(5-024) Utilizing Caenorhabditis Elegans as an Experimental Model to Study the Effects of G Protein Coupled Receptor Kinases on Behaviors Mediated by a Dopamine Transporter Inhibitor

(5-025) The Impact of Pharmacy Closures on Community Access and Patient Outcomes in New Hampshire: Legislation, Pharmacy Deserts, and Solutions

(5-026) Investigating Ibogaine as a Novel Therapy for PTSD and Substance Use Disorders in U.S. Veterans: Evidence, Limitations, and Global Context

(5-027) Literature Review of Investigational Therapies with New Mechanisms of Action in Sickle Cell Disease: Review of Active Phase 2 and 3 Clinical Trials from 2020-2025

(5-028) Evaluating the Neuroprotective Potential of Semaglutide in Alzheimer’s Disease

(5-029) Evaluating Online Consistency of Off-Label Drug Use Information for Type 2 Diabetes-Approved GLP-1 Receptor Agonists Used for Weight Loss

(5-030) Hyponatremia Diagnosis and Response Assessment (HYDRA)

(5-031) Medication Use Evaluation of Apixaban dosing and indication in a small community hospital

(5-032) Evaluating Commercially Available USP-Verified Dietary Supplements: Barriers and Opportunities for Individuals with Non-Meat Diets and Alpha-Gal Syndrome

(5-033) Literature Review on The Economic, Social, and Healthcare Impacts of Injectable HIV Medications Comparative to Oral HIV Medication for PrEP and Treatment

(5-034) Perceptions of Psychiatric Care Amongst Formerly Incarcerated Individuals